PRKAA2 and breast carcinoma: Having established thus far that AMPK regulates BCSC stemness and drug-resistance phenotypes, we wondered whether combinatorial targeting of this adaptive stress kinase, along with administration of the standard chemotherapeutic drug doxorubicin, would benefit breast cancer patients.